NovoCure‘s patent involves a method to inhibit viral infections by applying alternating electric fields to a target region, preventing viral infection of cells. The approach can be combined with antiviral agents for enhanced effectiveness. Target region must be tumor-free. GlobalData’s report on NovoCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on NovoCure, Neuromodulation implants was a key innovation area identified from patents. NovoCure's grant share as of May 2024 was 24%. Grant share is based on the ratio of number of grants to total number of patents.
Treating viral infections using alternating electric fields
A recently granted patent (Publication Number: US12011588B2) discloses a method for treating viral infections in subjects by applying an alternating electric field to a specific region of the body. The method involves inhibiting viral infection of cells in the target region, which is specified to be tumor-free. The alternating electric field utilized in the treatment has a defined frequency and field strength, with variations in orientation during the treatment process.
Furthermore, the method may also include the delivery of an antiviral agent to the subject in conjunction with the application of the alternating electric field. The frequency of the electric field typically falls within the range of 50 kHz to 500 kHz, with a field strength between 1 and 5 V/cm RMS. The duration of treatment can vary between 1 and 48 hours, with the orientation of the electric field being switched between different directions during this period. This innovative approach to treating viral infections showcases the potential for combining electrical stimulation with antiviral agents to combat such conditions effectively.
To know more about GlobalData’s detailed insights on NovoCure, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
